Basilea Pharmaceutica AG (SWX:BSLN)
52.60
-0.20 (-0.38%)
Mar 12, 2026, 5:30 PM CET
Basilea Pharmaceutica AG Employees
Basilea Pharmaceutica AG had 189 employees as of December 31, 2025. The number of employees increased by 25 or 15.24% compared to the previous year.
Employees
189
Change (1Y)
25
Growth (1Y)
15.24%
Revenue / Employee
1.23M CHF
Profits / Employee
212.91K CHF
Market Cap
649.00M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 189 | 25 | 15.24% |
| Dec 31, 2024 | 164 | 17 | 11.56% |
| Dec 31, 2023 | 147 | 6 | 4.26% |
| Dec 31, 2022 | 141 | -13 | -8.44% |
| Dec 31, 2021 | 154 | -3 | -1.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Molecular Partners AG | 153 |
| Santhera Pharmaceuticals Holding AG | 79 |
| BioVersys AG | 29 |
| Newron Pharmaceuticals | 22 |
| Xlife Sciences AG | 17 |
| Addex Therapeutics | 2 |
Basilea Pharmaceutica AG News
- 15 days ago - Basilea receives further USD 6 million from BARDA to continue development of novel antibiotic ceftibuten-ledaborbactam - GlobeNewsWire
- 22 days ago - Basilea Pharmaceutica Ltd (BPMUF) Full Year 2025 Earnings Call Highlights: Strong Revenue ... - GuruFocus
- 23 days ago - Full Year 2025 Basilea Pharmaceutica AG Allschwil Earnings Call Transcript - GuruFocus
- 23 days ago - Basilea Pharmaceutica AG (BPMUF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance - GlobeNewsWire
- 4 weeks ago - Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea - GlobeNewsWire
- 2 months ago - Basilea provides portfolio update and outlook - GlobeNewsWire
- 2 months ago - Prokaryotics and Basilea enter collaboration to develop a novel broad-spectrum antifungal for severe invasive infections - PRNewsWire